规格: | 98% |
分子量: | 295.4 |
包装 | 价格(元) |
10mg | 询价 |
25mg | 询价 |
50mg | 询价 |
100mg | 询价 |
Background:
Norquetiapine is an active metabolite of the atypical antipsychotic quetiapine .1It is formed from quetiapine primarily by the cytochrome P450 (CYP) isoform CYP3A4. Norquetiapine selectively inhibits the norepinephrine transporter (NET; IC50= 12 nM) over the serotonin (5-HT) and dopamine transporters (SERT and DAT; IC50s = 988 and >10,000 nM, respectively). It binds to the histamine H1receptor (Ki= 3.5 nM), as well as the 5-HT receptor subtypes 5-HT1, 5-HT2, and 5-HT7(Kis = 45-1,117 nM). It also binds to α1- and α2-adrenergic, dopamine D1-D5, and M1-M5muscarinic receptors (Kis = 95-736, 196-1,419, and 23-453 nM, respectively). It acts as an antagonist at histamine H1, α1A- and α1D-adrenergic, as well as M1, M3, and M5muscarinic receptors, in a concentration-dependent manner and as an agonist at the 5-HT1Areceptor (EC50= 4,898 nM). Norquetiapine (0.1, 0.5, and 1 mg/kg) reduces increases in immobility time in mice heterozygous for the gene encoding vesicular monoamine transporter 2 (Vmat2) but not in wild-type mice.
1.Jensen, N.H., Rodriguiz, R.M., Caron, M.G., et al.N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine’s antidepressant activityNeuropsychopharmacology33(10)2303-2312(2008)
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |